The agreement, under the Trump administration’s Operation Warp Speed, is for developing a monoclonal antibody cocktail that can prevent COVID-19, especially in high-risk population like those over 80 years old, the U.S. Department of Health and Human Services said. The treatment has come under the spotlight after Trump was treated with Regeneron Pharmaceuticals’ antibody drug last week. …read more
Source:: Yahoo Finance
